EICHOR
● Recruiting
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Condition: Major Depressive Disorder · Sponsor: Neurocrine Biosciences
About this study
This study will evaluate the long-term safety and tolerability of NBI-1065845 as an adjunctive treatment in participants with MDD.
This description comes directly from the study's public registry record.
Talk to the study team
Neurocrine Medical Information Call Center · 1-877-641-3461 · medinfo@neurocrine.com
Always discuss trial participation with your own doctor first.
Locations (106)
| Neurocrine Clinical Site | Huntsville, Alabama, United States | Recruiting |
| Neurocrine Clinical Site | Bryant, Arkansas, United States | Recruiting |
| Neurocrine Clinical Site | Little Rock, Arkansas, United States | Recruiting |
| Neurocrine Clinical Site | Glendale, California, United States | Recruiting |
| Neurocrine Clinical Site | Los Angeles, California, United States | Recruiting |
| Neurocrine Clinical Site | Oceanside, California, United States | Recruiting |
| Neurocrine Clinical Site | Orange, California, United States | Recruiting |
| Neurocrine Clinical Site | Pico Rivera, California, United States | Recruiting |
| Neurocrine Clinical Site | San Diego, California, United States | Recruiting |
| Neurocrine Clinical Site | San Francisco, California, United States | Recruiting |
| Neurocrine Clinical Site | San Jose, California, United States | Recruiting |
| Neurocrine Clinical Site | Upland, California, United States | Terminated |
+ 94 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06966401